Skip to content

Efficacy of RaktaPradarahara Yoga (Choorna) in Raktapradara W.S.R to Menorrhagia

A Randomised Comparative clinical study to evaluate the efficacy of RaktaPradarahara Yoga (Churna) over Pushyanuga Churna in Raktapradara W.S.R to Menorrhagia. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/078985
Enrollment
60
Registered
2025-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle

Interventions

None listed

Sponsors

Dr Preeti Autade
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients complaining of excessive menstrual bleeding a) Duration - More than 5 Days/21-35 days b) Quantity - More than Grade 2 Bleeding according to Pictorial Blood Assesement Scale (i.e. more than 3 pads per day). 2) Age between 15-40 years/ Married or Unmarried. 3) Patient excessive cyclic bleeding for atleast 3 consecutive cycles. 4) Patients with Acute and chronic Pelvic Inflammatory Disease. 5) Patients with Intra-Mural/Interstitial fibroids and Submucous fibroids.

Exclusion criteria

Exclusion criteria: 1. Patients present with bleeding due to Abortion, Pregnancy and Lactation will be excluded. 2. Patient with systemic and endocrine disorder interfering with the present study will be excluded like: Sexually Transmitted Diseases, Hyperthyroidism, Bleeding disorders, Tuberculosis. 3. Patients having Hb percentage 8 gm% or less than 8 gm%. 4. Patients with Intra Uterine Contraceptive Device and patients taking Oral Contraceptive Pills. 5. Patients taking Hormonal Replacement Therapy due to any cause. 6. Benign and malignant growth in the uterus. 7. Cases with pelvic pathology Ovarian Cyst, Endometriosis and Metorrhagia or Menometorrhagia. 8. Patients acquired Cervical Stenosis, Vaginal Atresia will be excluded. 9. Patients with Submucousal Uterine fibroid, Cervical fibroids, Polyps.

Design outcomes

Primary

MeasureTime frame
Reducing Excessive Menstrual BleedingTimepoint: 90 days

Secondary

MeasureTime frame
Reducing other related symptoms like Adhoudar shoola and Katishula based on gradings givenTimepoint: 90 days

Countries

India

Contacts

Public ContactDr Deepali Koli

Dr. N.A. MAGADUM AYURVEDIC MEDICAL COLLEGE, HOSPITAL AND RESEARCH CENTER, ANKALI-591213

drdeepali5119@gmail.com8975953456

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026